Management of iatrogenic crystalline lens injury occurred during intravitreal injection

Erdogan G., Gunay B. O., ÜNLÜ C., Gunay M., ERGİN A.

INTERNATIONAL OPHTHALMOLOGY, vol.36, no.4, pp.527-530, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 4
  • Publication Date: 2016
  • Doi Number: 10.1007/s10792-015-0156-5
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.527-530
  • Keywords: Intravitreal injection, Iatrogenic lens injury, Quiescent lens injury, Surgery, BEVACIZUMAB, COMPLICATIONS, RANIBIZUMAB, SAFETY
  • Karadeniz Technical University Affiliated: Yes


To evaluate the approach to management of iatrogenic crystalline lens injury occurred during intravitreal injection (IVI). The patients who were managed operatively or followed-up without intervention after the iatrogenic lens injury due to IVI were included in the study. Capsular breaks remained either quiescent or resulted in cataract formation in the patients with inadvertent crystalline lens capsule damage. Phacoemulsification surgery was performed in patients with cataract formation with lower fluidic settings. A total of 9 cases included in the study. Seven cases underwent phacoemulsification with intraocular lens implantation. Two cases remained as quiescent lens injury during the follow-up. In 2 cases, dislocation of lens fragments occurred during phacoemulsification where pars plana vitrectomy was performed at the same session. After iatrogenic crystalline lens injury, capsular damage could remain quiescent or progress to cataract formation. Although phacoemulsification surgery can be performed with appropriate parameters, lens fragment dislocation can be observed in cases with traumatic lens damage secondary to IVI.